Dr. Robert L. Worthington-Kirsch, MD

Dr. Worthington-Kirsch practices at United Vein & Vascular Centers in New Port Richey, Florida.

Dr. Worthington-Kirsch's NPI, 1013916436, was assigned on July 18, 2005. Dr. Worthington-Kirsch graduated from UMass Chan Medical School in 1986. Dr. Worthington-Kirsch holds Florida license ME154879.

Dr. Worthington-Kirsch's primary practice is United Vein & Vascular Centers, at 4619 Little Rd, New Port Richey, FL 34655 in Pasco County. The practice phone is (800) 991-6117.

Dr. Worthington-Kirsch's primary practice is United Vein & Vascular Centers in New Port Richey, Florida. The medical group on file is United Vein & Vascular Centers. Dmand AI also links Dr. Worthington-Kirsch to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Worthington-Kirsch practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Worthington-Kirsch's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Worthington-Kirsch is board certified in phlebology by the American Board of Phlebology. Dmand AI has Dr. Worthington-Kirsch's licenses on file in 10 states: Florida, California, Pennsylvania, New Jersey, Connecticut, Maryland, North Carolina, District of Columbia, Washington and Georgia.

CMS data shows 2,139 Medicare services from Dr. Worthington-Kirsch across 17 procedure codes in 2024, for 247 Medicare patients. Medicare paid $502,599 for them. Every service was in an office.

CMS counts 247 Medicare patients who saw Dr. Worthington-Kirsch in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Worthington-Kirsch's median patient age at 65, with 62% women.

In 2024, Dr. Worthington-Kirsch wrote 53 Medicare Part D claims for 24 patients. 58% of them were for generic drugs. CMS names the drug for 38 of them, across 2 drugs with 11 or more claims each, at $11,428 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

Dr. Worthington-Kirsch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of leg revascularization (restoring blood flow) by Dr. Worthington-Kirsch, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 37 papers to Dr. Worthington-Kirsch, published from 2010 to 2023. The most frequent topics are Leiomyoma, Uterine Neoplasms and Embolization, Therapeutic. Dr. Worthington-Kirsch has published most often in J Vasc Interv Radiol. Dr. Worthington-Kirsch's most frequent co-authors are James Spies, Gary P. Siskin and David Minas Hovsepian, MD.

Dmand AI links Dr. Worthington-Kirsch to 2 clinical trials. Conditions studied include Leiomyomatosis, Varicose Veins and Leiomyoma.

CMS Open Payments shows 90 general payments to Dr. Worthington-Kirsch from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $4,629.

Dmand AI lists 3 awards for Dr. Worthington-Kirsch, most recently Fellow in 2014.

Dr. Worthington-Kirsch graduated from UMass Chan Medical School in 1986. Dr. Worthington-Kirsch is a member of SIR.

Dr. Worthington-Kirsch is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.